485 related articles for article (PubMed ID: 19010192)
1. Influence of traditional cardiovascular risk factors in the recipient on the development of cardiac allograft vasculopathy after heart transplantation.
Sánchez Lázaro IJ; Almenar Bonet L; Moro López J; Sánchez Lacuesta E; Martínez-Dolz L; Agüero Ramón-Llín J; Andrés Lalaguna L; Cano Pérez O; Ortiz Martínez V; Buendía Fuentes F; Salvador Sanz A
Transplant Proc; 2008 Nov; 40(9):3056-7. PubMed ID: 19010192
[TBL] [Abstract][Full Text] [Related]
2. Do cardiovascular risk factors influence cardiac allograft vasculopathy?
Chamorro CI; Almenar L; Martínez-Dolz L; Sánchez-Lacuesta E; Martín-Pastor J; Ten-Morro F; Sánchez-Soriano RM; Agüero J; Ortiz V; Moro JA; Salvador A
Transplant Proc; 2006 Oct; 38(8):2572-4. PubMed ID: 17098006
[TBL] [Abstract][Full Text] [Related]
3. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806
[TBL] [Abstract][Full Text] [Related]
4. Effect of hypertension, diabetes, and smoking on development of renal dysfunction after heart transplantation.
Sánchez Lázaro IJ; Almenar Bonet L; Martínez-Dolz L; Moro López J; Agüero Ramón-Llín J; Cano Pérez O; Rueda Soriano J; Buendía Fuentes F; Navarro Manchón J; Raso Raso R; Salvador Sanz A
Transplant Proc; 2008 Nov; 40(9):3049-50. PubMed ID: 19010189
[TBL] [Abstract][Full Text] [Related]
5. Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
Valantine H
J Heart Lung Transplant; 2004 May; 23(5 Suppl):S187-93. PubMed ID: 15093804
[TBL] [Abstract][Full Text] [Related]
6. Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients.
Kobashigawa JA; Starling RC; Mehra MR; Kormos RL; Bhat G; Barr ML; Sigouin CS; Kolesar J; Fitzsimmons W
J Heart Lung Transplant; 2006 Sep; 25(9):1063-9. PubMed ID: 16962467
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for development of diabetes mellitus post-heart transplant.
Martínez-Dolz L; Almenar L; Martínez-Ortiz L; Arnau MA; Chamorro C; Moro J; Osa A; Rueda J; García C; Palencia M
Transplant Proc; 2005 Nov; 37(9):4064-6. PubMed ID: 16386627
[TBL] [Abstract][Full Text] [Related]
8. Influence of metabolic syndrome on development of cardiac allograft vasculopathy in the transplanted heart.
Sánchez-Gómez JM; Martínez-Dolz L; Sánchez-Lázaro I; Almenar L; Sánchez-Lacuesta E; Muñoz-Giner B; Portolés M; Rivera M; Valera-Román A; González-Juanatey JR; Tejada-Ponce D; Agüero J; Buendía F; Salvador A
Transplantation; 2012 Jan; 93(1):106-11. PubMed ID: 22134367
[TBL] [Abstract][Full Text] [Related]
9. The influence of cytomegalovirus infection, confirmed by pp65 antigen presence, on the development of cardiac allograft vasculopathy.
Zakliczyński M; Krynicka-Mazurek A; Pyka Ł; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M
Transplant Proc; 2007 Nov; 39(9):2866-9. PubMed ID: 18022004
[TBL] [Abstract][Full Text] [Related]
10. Hypertension after heart transplantation: predictive factors and number and classes of drugs for its management.
Sánchez Lázaro IJ; Almenar Bonet L; Martínez-Dolz L; Moro López J; Ramón-Llín JA; Pérez OC; Soriano JR; Fuentes FB; Manchón JN; Sánchez Gómez JM; Sanz AS
Transplant Proc; 2008 Nov; 40(9):3051-2. PubMed ID: 19010190
[TBL] [Abstract][Full Text] [Related]
11. Dobutamine stress echocardiography predicts cardiac events or death in asymptomatic patients long-term after heart transplantation: 4-year prospective evaluation.
Bacal F; Moreira L; Souza G; Rodrigues AC; Fiorelli A; Stolf N; Bocchi E; Bellotti G; Ramires JA
J Heart Lung Transplant; 2004 Nov; 23(11):1238-44. PubMed ID: 15539121
[TBL] [Abstract][Full Text] [Related]
12. Blood glutathione as a marker of cardiac allograft vasculopathy in heart transplant recipients.
De Chiara B; Bigi R; Campolo J; Parolini M; Turazza F; Masciocco G; Frigerio M; Fiorentini C; Parodi O
Clin Transplant; 2005 Jun; 19(3):367-71. PubMed ID: 15877800
[TBL] [Abstract][Full Text] [Related]
13. Heart rate and cardiac allograft vasculopathy in heart transplant recipients.
Olmetti F; Pinna GD; Maestri R; D'Armini A; Pellegrini C; Viganò M; Lilleri D; Gerna G; Febo O; La Rovere MT
J Heart Lung Transplant; 2011 Dec; 30(12):1368-73. PubMed ID: 21840733
[TBL] [Abstract][Full Text] [Related]
14. Relationship between bridging with ventricular assist device on rejection after heart transplantation.
Pamboukian SV; Costanzo MR; Dunlap S; Rayburn B; Westfall AO; You ZY; Hung E; McLeod M; Heroux A
J Heart Lung Transplant; 2005 Mar; 24(3):310-5. PubMed ID: 15737758
[TBL] [Abstract][Full Text] [Related]
15. Treatment and prophylaxis of cardiac allograft vasculopathy.
Wang SS
Transplant Proc; 2008 Oct; 40(8):2609-10. PubMed ID: 18929815
[TBL] [Abstract][Full Text] [Related]
16. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease.
Jonas M; Fang JC; Wang JC; Giri S; Elian D; Har-Zahav Y; Ly H; Seifert PA; Popma JJ; Rogers C
J Am Coll Cardiol; 2006 Aug; 48(3):453-61. PubMed ID: 16875968
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cardiovascular risk factors and complications before and after kidney transplantation.
Fazelzadeh A; Mehdizadeh A; Ostovan MA; Raiss-Jalali GA
Transplant Proc; 2006 Mar; 38(2):506-8. PubMed ID: 16549161
[TBL] [Abstract][Full Text] [Related]
18. Low serum IGF-1 is a risk factor for cardiac allograft vasculopathy in cardiac transplant recipients.
Aharinejad S; Salama M; Rödler S; Ehrlich M; Zuckermann A; Laufer G
Transplantation; 2012 Feb; 93(3):309-13. PubMed ID: 22217530
[TBL] [Abstract][Full Text] [Related]
19. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation.
Mahle WT; Vincent RN; Berg AM; Kanter KR
J Heart Lung Transplant; 2005 Jan; 24(1):63-6. PubMed ID: 15653381
[TBL] [Abstract][Full Text] [Related]
20. Cardiac allograft vasculopathy: current knowledge and future direction.
Colvin-Adams M; Agnihotri A
Clin Transplant; 2011; 25(2):175-84. PubMed ID: 21457328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
